Securities Claims Against Drug Maker, CEO Survive Dismissal Bid
BROOKLYN, N.Y. — A federal judge in New York on March 10 partially granted a motion to dismiss in a securities class action lawsuit against a biopharmaceutical company and certain of...To view the full article, register now.
Already a subscriber? Click here to view full article